Impact Factor
3.16
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.75
244 total citations
h5-index
21
h5 depth signal
Cited share
67.4%
64 of 95
Total citations
244
Citation footprint
Metric signal
2.85
External metric anchor
Self-citation
0.4%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
93
China
41
United Kingdom
41
Japan
35
Netherlands
28
Citing Fields of Research
Neurodegenerative Disorders
517
Palliative Care
79
Neurosciences
60
Psychiatry
31
Aging & Longevity
24
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,185
Articles tracked across the journal lifetime
Indexed publication set
95
64 cited publications
Last 12 months
50
4.5 publications/month
Open access share
20.0%
10 OA publications in the last year
Leading citing country
United States
93 citing publications
Leading citing field
Neurodegenerative Disorders
517 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v8n1,Jan.-Feb. 1997-
v8n1,Jan.-Feb. 1997-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Broad Categories
Geriatrics
Neurology
Psychiatry
Neurodegenerative Disorders
MeSH Descriptors
Aged
Cognition Disorders
Dementia
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1159/dem/aciag014
Open DOI
Location matters: Attributing cognitive symptoms to white matter hyperintensities in 3,481 memory clinic patients
Background and aim: In memory clinic patients, assessing diagnostic relevance of white matter hyperintensities (WMHs), as a marker to explain cognitive deficits, can be challenging. Here, we aimed to quantify this relevance by measuring ...
02
DOI 10.1159/dem/aciag008
Open DOI
Gait-Based Machine Learning Model for Detecting Prevalent Mild Cognitive Impairment in Older Chinese Adults: A Community-Based Cross-Sectional Study
Introduction: Detection of prevalent mild cognitive impairment (MCI) is difficult. We tested whether adding gait features to clinical variables improved prevalent MCI classification among older adults. Methods: This cross-sectional analy...
03
DOI 10.1159/dem/aciag011
Open DOI
Uniform Dataset 3 Neuropsychological Battery: Czech Normative Study of a Battery assessing cognitive functioning in older adults
Introduction: The Uniform Data Set Neuropsychological Battery, version 3 (UDSNB 3), is a comprehensive, non-proprietary tool designed to assess cognitive domains relevant to neurodegenerative disorders, particularly Alzheimer’s disease. ...
04
DOI 10.1159/dem/aciag010
Open DOI
Symptom-Guided Blood Biomarker Testing for Alzheimer’s Disease
Introduction Blood-based biomarkers can accurately detect Alzheimer’s disease (AD) pathology, but symptom-guided testing approaches are understudied. This study evaluated the utility of early symptom and biomarker changes in predicting c...
05
DOI 10.1159/dem/aciag013
Open DOI
Efficacy of Levetiracetam Combined with Sodium Valproate (Oral) in the Treatment of Senile Epilepsy and Its Effects on Cognitive Function, Inflammatory Factors and Neurotransmitters
Objective: To evaluate the clinical efficacy of levetiracetam combined with oral sodium valproate in elderly patients with epilepsy and to assess its effects on cognitive function, inflammatory markers, and neurotransmitter levels. Metho...
06
DOI 10.1159/dem/aciag009
Open DOI
Informant Presence Fails to Enhance Alzheimer’s Diagnosis in Complex Veteran Cases
Introduction: Informant reports are thought helpful for Alzheimer's disease (AD) diagnosis. We hypothesized that informants would improve diagnostic accuracy, operationalized as agreement between clinical impression and amyloid PET (aPET...
07
DOI 10.1159/dem/aciag007
Open DOI
Anxiety Symptoms and Risk of Dementia Progression in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
Introduction: Anxiety is among the earliest and most common neuropsychiatric symptoms in cognitive impairment. Emerging evidence suggests that anxiety may elevate the risk of cognitive decline in mild cognitive impairment (MCI). This sys...
08
DOI 10.1159/dem/aciag006
Open DOI
Longitudinal Association between Day Service Use and Regular Memory Clinic Attendance in Alzheimer’s Disease: A 3-Year Retrospective Observation of Completers
Introduction: Alzheimer’s disease (AD) is a common progressive cognitive disease. Day services (DSs) are provided through the Japanese public nursing care system. This study examined the association between DS utilization and regular mem...
09
DOI 10.1159/dem/aciag005
Open DOI
Initial Psychometric Evaluation of the Riga Cognitive Screening Task (RiTa) in Older Adults with Varying Levels of Cognitive Functioning
Introduction: Cognitive impairment remains underdetected in clinical practice, with prevalence estimates exceeding the official statistics. Most existing screening tools rarely extend beyond cognitive performance to capture the broader c...
10
DOI 10.1159/dem/aciag004
Open DOI
Epigenetic Aging Clocks Associate with Cognitive Status More Strongly than Short-Term Cognitive Change: Evidence from the Parkinson’s Progression Markers Initiative
Introduction: Cognitive impairment is a major source of disability in Parkinsonian disorders, yet biomarkers that distinguish cognitive status from cognitive decline remain limited. DNA methylation-based epigenetic aging (EA) measures ca...
Bibliographical & Catalog Notes
Title from cover.
Called also v. 8, no. 1- .
Also issued online.
Vol. 8, no. 1 (JAN-FEB 1997)19970304 Notice published Printed on acid-free paper